Ultrasonographic characterization in patients with Peyronie's disease

Authors

  • Moraima Álvarez Moreno Facultad de Ciencias Médicas de Artemisa, Hospital General Docente Comandante Pinares. San Cristóbal, Artemisa, Cuba Author https://orcid.org/0000-0002-9145-7182
  • Antonio Armando Lamelas Testa Facultad de Ciencias Médicas de Artemisa, Hospital General Docente Comandante Pinares. San Cristóbal, Artemisa, Cuba Author https://orcid.org/0000-0002-3281-6966
  • Anadely Gámez Pérez Facultad de Ciencias Médicas de Artemisa, Hospital General Docente Comandante Pinares. San Cristóbal, Artemisa, Cuba Author https://orcid.org/0000-0003-4431-1153
  • Lázaro Silva Ramos Facultad de Ciencias Médicas de Artemisa. Servicios de Hospitalización Manuel Gonzales Díaz. Bahía Honda, Artemisa. Cuba Author https://orcid.org/0000-0003-2183-0372
  • Eledys Márquez Blanco Facultad de Ciencias Médicas de Artemisa, Hospital General Docente Comandante Pinares. San Cristóbal, Artemisa, Cuba Author https://orcid.org/0000-0002-5697-407X
  • Delia Rosa Díaz Rodríguez Facultad de Ciencias Médicas de Artemisa Dirección de Salud. San Cristóbal. Artemisa, Cuba Author https://orcid.org/0000-0001-6121-7922
  • Catherine Milagros Fajardo Borges Facultad de Ciencias Médicas de Artemisa, Cuba Author

DOI:

https://doi.org/10.56294/shp2025183

Keywords:

Peyronie's disease, penile deviation, ultrasonography, hardened plaques in the penis

Abstract

Introduction: Peyronie's disease is a connective tissue disorder that presents as indurations or plaques, which are painful in the early phase of its evolution, especially with erection.
Objective: To describe the ultrasonographic characteristics of lasting plaques in patients diagnosed with Peyronie's  disease.
Methods: A descriptive, cross-sectional study was carried out on patients treated at the Comandante Pinares General Teaching Hospital in the urology and Imaging services in the period between January 2015 and June 2022. The universe was 245 patients with Peyronie's disease, selected Using a probabilistic method, a sample of 159 was studied. The variables were studied: age, skin color, initial deviation of the penis, ultrasonographic findings, number of simple calcifications and calcified plaques. Descriptive statistics are used to process the information. Results: White patients between 50 and 59 years of age predominated. The average age was 52.2 ± 6.8 years. The plaque was located more frequently on the dorsal surface greater than 60%. Simple calcifications prevailed with 103 (64.8%) followed by calcified plaques with 56 (35.2%) According to size, large calcifications predominated with 85 patients for 82.5%. Regarding calcified plaques, the large ones obtained the highest value with 30 for 53.5%.Conclusions: Ultrasound was a useful technique to achieve the description of linear images with the appearance of fibrocalcifications in patients with Peyronie's disease.

References

1. Angulo Moya LC, Garita Méndez EA, Salas Morgan JP. Enfermedad de Peyronie. Rev.méd.sinerg. [Internet]. 1 de abril de 2022 [citado 20 de julio de 2022];7(4):e747. Disponible en: https://www.revistamedicasinergia.com/index.php/rms/article/view/747

2. Cohen S D. Diagnosis and Treatment of Peyronie Disease With Both Dorsal and Ventral Plaques Using Doppler Ultrasound: NYU Case of the Month, July 2019.Re views in Urology, 21(2-3), 127. Disponible en: https://w ww.ncbi.nlm .nih.gov/pmc/articles/PMC6864913/3.

3. Gaffney CD, Kashanian J A. Peyronie disease. Jama. 2020;324(24), 2566-2566. Disponible en: https://jamanetwork.com/journals/jama/article-abstract/2774409

4. Chung E, Yafi FA. Pharmacotherapy in Peyronie's disease: a state-of-the-art review on established contemporary and emerging drugs. Expert Opin Pharmacother. 2022. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35209789/

5. El-Sakka, AI. Medical, non-invasive, and minimally invasive treatment for Peyronie’s disease: A systematic review. Andrology. 2021; 9: 511– 528 2022. Disponible en: https://doi.org/10.1111/andr.12927

6. Sandean D, Lotfollahzadeh S. Peyronie Disease. 2021. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK560628

7. Aita Giuliano, Ros Carlos Teodósio da, Silvinato Antonio, Bernardo Wanderley Marques. Peyronie’s disease: clinical treatment. Rev. Assoc. Med. Bras. [Internet]. 2019 Oct [cited 2020 Nov 30] ; 65( 10 ): 1231-1239.Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019001001231&lng=en. Epub Nov 07, 2019.

8. Yousif A, Natale C, Hellstrom WJG.Terapia conservadora para la enfermedad de Peyronie: una revisión contemporánea de la literatura. Curr Urol Rep.2022;22(6) Disponible en: https://link.springer.com/article/10.1007/s11934-020-01024-8#citeas

9. Paulis G, De Giorgio G. Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases. Am J Case Rep. 2022. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022185/

10. WMA. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos; 2013 Disponible en: http://www.revurologia.sld.cu/index.php/rcu/article/view/373/368

11. Seftel AD, Yang H. Diagnosis and Management of Peyronie’s Disease. In: Campbell Walsh Wein Urology. 12th ed. Elsevier Health; 2020: 1599–626.

12. Farrell MR, Ziegelmann MJ, Levine LA. Minimally invasive therapies for Peyronie's disease: the current state of the art. Transl Androl Urol.2020;9(Suppl 2):S269-S283. doi:10.21037/tau.2019.08.06

13. Gabrielsen JS. Peyronie's disease: is it genetic or not?. Transl Androl Urol. 2020;9(Suppl 2):S262-S268. doi:10.21037/tau.2019.10.21

14. Babu A and Kayes O. Recent advances in managing Peyronie’s disease [version 1; peer review: 2 approved]. F1000Research 2020, 9(F1000 Faculty Rev):381 (https://doi.org/10.12688/f1000research.20557.1)

15. Trama F, Illiano E, Iacono F. Ruffo A, di Lauro G, Aveta A , et al. Use of penile shear wave elastosonography for the diagnosis of Peyronie’s Disease: a prospective case–control study. Basic Clin. Androl. 32, 15 (2022). https://doi.org/10.1186/s12610-022-00164-w

16. Da Silva M, Dávila F, Rosito T, Martins F. Global Perspective on the Management of Peyronie's Disease. Frontiers in Reproductive Health. 2022. Disponible en: https://www.frontiersin.org/articles/10.3389/frph.2022.863844

17. Nascimento B, Miranda EP, Terrier JE, Carneiro F, Mulhall JP. A Critical Analysis of Methodology Pitfalls in Duplex Doppler Ultrasound in the Evaluation of Patients With Erectile Dysfunction: Technical and Interpretation Deficiencies. J Sex Med. 2020;17(8):1416-22. PMID: 32631763; https://doi. org/10.1016/j.jsxm.2020.05.023.

18. Piamo-Morales AJ, García-Rojas MA. Uso de la elastosonografía en el diagnóstico de la enfermedad de Peyronie. Acta Médica del Centro. 2020;14(2):257–67.

19. Illiano E, Trama F, Ruffo A, Romeo G, Riccardo F, Iacono F, et al. Shear wave elastography as a new, non-invasive diagnostic modality for the diagnosis of penile elasticity: a prospective multicenter study. Ther Adv Urol. 2021;13:17562872211007978.

20. Parmar M, Masterson JM, Masterson TA 3rd. The role of imaging in the diagnosis and management of Peyronie’s disease. Curr Opin Urol. 2020;30:283–9.

21. Noleto WG, Gersgorin STS, Mendonça V de P, Vasconcelos ALC, Vilela CO, de Moura Álvaro I, da Silva JID, Tortato K, Kikuchi GI, Pôrto HBG, Guimarães MS, Brito R de O, Marques AM, Karaja SN, de Oliveira IL, Souza JP. Doença de Peyronie: uma abordagem diagnóstica, evolução clínica e revisão. Braz. J. Hea. Rev. [Internet]. 2023 Sep. 18 [cited 2024 Feb. 7];6(5):21983-92. Disponible en: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/63190Conflicto de intereses

Downloads

Published

2025-04-22

How to Cite

1.
Álvarez Moreno M, Lamelas Testa AA, Gámez Pérez A, Silva Ramos L, Márquez Blanco E, Díaz Rodríguez DR, et al. Ultrasonographic characterization in patients with Peyronie’s disease. South Health and Policy [Internet]. 2025 Apr. 22 [cited 2025 Sep. 17];4:183. Available from: https://shp.ageditor.ar/index.php/shp/article/view/183